Treatment of Hepatitis C With Direct-Acting Antivirals in Patients With Hepatocellular Carcinoma Before Liver Transplantation: Still an Open Issue

Liver Transplantation - United States
doi 10.1002/lt.24962
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

“DAA in Patients With Hepatocellular Carcinoma Before Liver Transplantation: Are We Sure Is Still an Open Issue?”

Liver Transplantation
HepatologyTransplantationSurgery
2017English

Unexpected Viral Relapses in Hepatitis C Virus-Infected Patients Diagnosed With Hepatocellular Carcinoma During Treatment With Direct-Acting Antivirals

Hepatology
MedicineHepatology
2017English

Hepatitis C Related Hepatocellular Carcinoma in the Era of Direct-Acting Antivirals

Hepatoma Research
2018English

Treatment Efficacy for Patients With Chronic Hepatitis C and Preexisting Hepatocellular Carcinoma by Directly Acting Antivirals

Hepatoma Research
2020English

Hepatocellular Carcinoma Decreases the Chance of Successful Hepatitis C Virus Therapy With Direct-Acting Antivirals

Journal of Hepatology
Hepatology
2017English

The Interplay Between Direct-Acting Antivirals and Hepatocellular Carcinoma in Chronic Hepatitis C

Hepatoma Research
2020English

Increased Incidence or Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Cirrhotic Patients Treated With Direct-Acting Antivirals: Myth or Fact?

Expert Review of Anticancer Therapy
OncologyPharmacology
2018English

Direct-Acting Antivirals and Recurrence of Hepatocellular Carcinoma

Liver Transplantation
HepatologyTransplantationSurgery
2017English

Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C: Open Issues and Future Perspectives

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy